ID

16730

Beskrivning

Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc (OSI Pharmaceuticals) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part of study: Concomitant Medications

Länk

https://clinicaltrials.gov/ct2/show/NCT00373425

Nyckelord

Versioner (2)
  1. 2016-08-02 2016-08-02 -
  2. 2016-08-03 2016-08-03 - Julian Varghese
Uppladdad den

3 augusti 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Concomitant Medications, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425

Engelsk

Concomitant Medications, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 Formulär  
Concomitant Medications
Beskrivning

Concomitant Medications

Concomitant Medication
Beskrivning

Concomitant Medication

Datatyp

boolean

Alias
UMLS CUI [1]
C2347852
Medications
Beskrivning

Medications

Medication (Use generic name when possible)
Beskrivning

Concomitant Medication

Datatyp

text

Alias
UMLS CUI [1]
C2347852
Prophylaxis
Beskrivning

Indication Prophylaxis

Datatyp

boolean

Alias
UMLS CUI [1,1]
C2826696
UMLS CUI [1,2]
C0199176
Indication
Beskrivning

Indication

Datatyp

text

Alias
UMLS CUI [1]
C2826696
Date started: Prestudy
Beskrivning

Concomitant Medication Start Date

Datatyp

boolean

Alias
UMLS CUI [1]
C2826734
Date started
Beskrivning

Concomitant Medication Start Date

Datatyp

date

Alias
UMLS CUI [1]
C2826734
Date stopped: Post treatment
Beskrivning

Concomitant Medication End Date

Datatyp

boolean

Alias
UMLS CUI [1]
C2826744
Date stopped
Beskrivning

Concomitant Medication End Date

Datatyp

date

Alias
UMLS CUI [1]
C2826744
Tillbaka till toppen

Similar models

Concomitant Medications, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Concomitant Medications
Concomitant Medication
Item
Concomitant Medication
boolean
C2347852 (UMLS CUI [1])
Item Group
Medications
Concomitant Medication
Item
Medication (Use generic name when possible)
text
C2347852 (UMLS CUI [1])
Indication Prophylaxis
Item
Prophylaxis
boolean
C2826696 (UMLS CUI [1,1])
C0199176 (UMLS CUI [1,2])
Indication
Item
Indication
text
C2826696 (UMLS CUI [1])
Concomitant Medication Start Date
Item
Date started: Prestudy
boolean
C2826734 (UMLS CUI [1])
Concomitant Medication Start Date
Item
Date started
date
C2826734 (UMLS CUI [1])
Concomitant Medication End Date
Item
Date stopped: Post treatment
boolean
C2826744 (UMLS CUI [1])
Concomitant Medication End Date
Item
Date stopped
date
C2826744 (UMLS CUI [1])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial